⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8420119 | 1.00 | — | — | |
| SCHEMBL10629749 | 1.00 | — | — | |
| SCHEMBL18266878 | 1.00 | — | — | |
| SCHEMBL3367148 | 1.00 | — | — | |
| SCHEMBL5119518 | 0.84 | — | — | |
| SCHEMBL11769202 | 0.78 | — | — | |
| SCHEMBL303459 | 0.76 | — | — | |
| SCHEMBL11078940 | 0.75 | — | — | |
| SCHEMBL1065685 | 0.75 | — | — | |
| SCHEMBL8256581 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3833668-B1 | PRMT5 INHIBITORS | MERCK SHARP & DOHME LLC (US) | 2025-03-19 | — | — | EP | claimed |
| WO-2024029877-A1 | NOVEL PURINE DERIVATIVE COMPOUNDS AS A3 ADENOSINE RECEPTOR AGONISTS | 주식회사 넥스트젠바이오사이언스 | 2024-02-08 | — | — | WO | claimed |
| EP-2219260-B1 | ELECTROLYTIC COMPOSITION AND PHOTOELECTRIC CONVERSION ELEMENT USING THE SAME | FUJIKURA LTD (JP) | 2015-11-04 | — | — | EP | claimed |
| EP-2142549-A1 | ADENOSINE DERIVATIVES, METHOD FOR THE SYNTHESIS THEREOF, AND THE PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF THE INFLAMMATORY DISEASES CONTAINING THE SAME AS AN ACTIVE INGREDIENT | FM Therapeutics Co., Ltd. (KR) | 2010-01-13 | — | — | EP | claimed |
| WO-2008108508-A1 | ADENOSINE DERIVATIVES, METHOD FOR THE SYNTHESIS THEREOF, AND THE PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF THE INFLAMMATORY DISEASES CONTAINING THE SAME AS AN ACTIVE INGREDIENT | FM THERAPEUTICS CO., LTD. (KR) | 2008-09-12 | — | — | WO | claimed |
| EP-0885940-B1 | Ink jet inks comprising anti-curl agents and printing processes | XEROX CORP (US) | 2008-02-20 | — | — | EP | claimed |
| US-5997623-A | Ink jet inks comprising anti-curl agents and printing processes | XEROX CORPORATION (US) | 1999-12-07 | — | — | US | claimed |
| EP-0885940-A1 | Ink jet inks comprising anti-curl agents and printing processes | XEROX CORPORATION (US) | 1998-12-23 | — | — | EP | claimed |
| US-4288433-A | THIOETHER AND A XANTHINE DERIVATIVE | L'OREAL (FR) | 1981-09-08 | — | — | US | claimed |
| US-3950532-A | ANTIDANDRUFF | L'OREAL (FR) | 1976-04-13 | — | — | US | claimed |
| JP-62169777-A | — | — | None | — | — | JP | disclosed |
| US-11993602-B2 | PRMT5 inhibitors | MERCK SHARP & DOHME LLC (US) | 2024-05-28 | — | — | US | disclosed |
| WO-2024029877-A1 | NOVEL PURINE DERIVATIVE COMPOUNDS AS A3 ADENOSINE RECEPTOR AGONISTS | 주식회사 넥스트젠바이오사이언스 | 2024-02-08 | — | — | WO | disclosed |
| EP-4234021-A2 | PHARMACEUTICAL COMPOSITION COMPRISING AN ADENOSINE DERIVATIVE FOR USE IN THE PREVENTION OR TREATMENT OF DIABETIC NEPHROPATHY | Future Medicine Co., Ltd. (KR) | 2023-08-30 | — | — | EP | disclosed |
| CN-116350649-A | Pharmaceutical composition for preventing and/or treating cholangitis or liver diseases caused by cholangitis | 未来制药有限公司 | 2023-06-30 | — | — | CN | disclosed |
| US-4080465-A | Topical application of cis or trans 3,4-thiolannediol to reduce or substantially eliminate the greasy appearance of the skin | SOCIETE ANONYME DITE: L'OREAL (FR) | 1978-03-21 | — | — | US | disclosed |
| US-4080465-A | Topical application of cis or trans 3,4-thiolannediol to reduce or substantially eliminate the greasy appearance of the skin | SOCIETE ANONYME DITE: L'OREAL (FR) | 1978-03-21 | — | — | US | disclosed |
| US-3950532-A | ANTIDANDRUFF | L'OREAL (FR) | 1976-04-13 | — | — | US | disclosed |
| US-3950532-A | ANTIDANDRUFF | L'OREAL (FR) | 1976-04-13 | — | — | US | disclosed |
| US-3950532-A | ANTIDANDRUFF | L'OREAL (FR) | 1976-04-13 | — | — | US | disclosed |